NCT00391560View on ClinicalTrials.gov

Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia

PHASE2CompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2011

Conditions

Leukemia

Interventions

DRUG

perifosine

Identical intervention in both arms.

Sponsors

Lead Sponsor

AEterna Zentaris

All Listed Sponsors

lead

AEterna Zentaris

INDUSTRY